Navigation Links
Are cancers newly evolved species?
Date:7/26/2011

Cancer patients may view their tumors as parasites taking over their bodies, but this is more than a metaphor for Peter Duesberg, a molecular and cell biology professor at the University of California, Berkeley.

Cancerous tumors are parasitic organisms, he said. Each one is a new species that, like most parasites, depends on its host for food, but otherwise operates independently and often to the detriment of its host.

In a paper published in the July 1 issue of the journal Cell Cycle, Duesberg and UC Berkeley colleagues describe their theory that carcinogenesis the generation of cancer is just another form of speciation, the evolution of new species.

"Cancer is comparable to a bacterial level of complexity, but still autonomous, that is, it doesn't depend on other cells for survival; it doesn't follow orders like other cells in the body, and it can grow where, when and how it likes," said Duesberg. "That's what species are all about."

This novel view of cancer could yield new insights into the growth and metastasis of cancer, Duesberg said, and perhaps new approaches to therapy or new drug targets. In addition, because the disrupted chromosomes of newly evolved cancers are visible in a microscope, it may be possible to detect cancers earlier, much as today's Pap smear relies on changes in the shapes of cervical cells as an indication of chromosomal problems that could lead to cervical cancer.

Carcinogenesis and evolution

The idea that cancer formation is akin to the evolution of a new species is not new, with various biologists hinting at it in the late 20th century. Evolutionary biologist Julian S. Huxley wrote in 1956 that "Once the neoplastic process has crossed the threshold of autonomy, the resultant tumor can be logically regarded as a new biologic species ."

Last year, Dr. Mark Vincent of the London Regional Cancer Program and University of Western Ontario argued in the jou
'/>"/>

Contact: Robert Sanders
rsanders@berkeley.edu
510-643-6998
University of California - Berkeley
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. 2 genetic variations predict second cancers after radiation for children with Hodgkin lymphoma
2. Novel pathway regulating angiogenesis may fight retinal disease, cancers
3. Sandia and UNM lead effort to destroy cancers
4. Study shows new treatment strategy effective for certain lung cancers
5. Blocking rogue gene could stop the spread of most cancers
6. An earlier start on diagnosing breast, prostate cancers
7. Researchers discover genetic predisposition for breast, kidney cancers
8. Combination therapy reduced HER2-positive breast cancers
9. Discovery of a mechanism that controls the expression of a protein involved in numerous cancers
10. Clue to unusual drug-resistant breast cancers found
11. Fighting cancers by tagging their triggers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2015)... 2015 According to ... Market by Product (Cards and Readers, Biometrics, Controllers, Management ... Industrial, Healthcare, Education) and By Geography - Global Forecast and Analysis ... Access Control Market is expected to reach ... CAGR of 10.6% between 2014 and 2020. ...
(Date:2/5/2015)... , 5. Februar 2015 Marken ... Logistikunternehmen und hat eine neue Marketingkampagne gestartet, ... (Clinical Logistics Organization – CLO) der Branche ... lautet First , mit Schwerpunkt auf ... http://photos.prnewswire.com/prnh/20150205/173753 Logo - ...
(Date:2/5/2015)... , Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... corporate website ( http://www.nxt-id.com/ ) as part of its ... wallet. The Company launched its new consumer website for ... Pereira , CEO of NXT-ID said, "Our new corporate ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... frontier for pharmaceutical makers. Even after they discover a ... wonder drug, however, they have to confront a long-standing ... in a highly pure state. Now, a multi-institutional research ... Standards and Technology (NIST) may have found* a new ...
... polluting industrial processes can be made safer with enzymes. ... available for the chemical industry. , Recently a group ... of Copenhagen succeeded in producing an artificial enzyme that ... , With their group leader, Professor Mikael Bols, Ph.d. ...
... TORONTO, October 22, 2009 New research shows that ... a premature death unless they perform an adequate courtship ... research shows that "sneaker" males can slip by and ... first suitor. Scientists at the University of ...
Cached Biology News:Biochemical 'on-switch' could solve protein purification challenge 2New artificial enzyme safer for nature 2Male Australian redback spiders employ courtship strategies to preserve their life 2
(Date:3/3/2015)... Mass. (PRWEB) March 03, 2015 Cambridge ... by Semantic Web technology, today announced that it has ... Companies That Matter in Knowledge Management.’ , To ... group of colleagues, analysts and system integrators who identify ... delivery of the right information to the right people ...
(Date:3/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/qcdj5m/rnai ) ... "RNAi - Technologies, Markets and Companies" to ... ability to silence any gene once the sequence is ... to discriminate gene function. After the genome of an ... every gene in the genome and target for specific ...
(Date:3/3/2015)... SAN FRANCISCO , March 3, 2015  Johnson ... JLABS @ South San Francisco (JLABS ... Point Boulevard, South San Francisco, Calif. ... can accommodate up to 50 startups from across the ... digital health.  The first resident startups ...
(Date:3/3/2015)... DNA Diagnostics Center (DDC), one of the largest ... 20 th anniversary today. Headed by President and ... services company that focuses on DNA testing across multiple ... generates a significant portion of sales across international markets ... Peter Vitulli acknowledges the anniversary of the ...
Breaking Biology Technology:Cambridge Semantics Named to KMWorld’s 2015 ‘100 Companies That Matter in Knowledge Management’ 2Global RNAi Market Report 2015 - Technologies, Markets and Companies 2014-2024 2Global RNAi Market Report 2015 - Technologies, Markets and Companies 2014-2024 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 2Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 4Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 5DNA Diagnostics Center, One of The World's Largest DNA Testing Labs, Celebrates Their 20th Anniversary 2DNA Diagnostics Center, One of The World's Largest DNA Testing Labs, Celebrates Their 20th Anniversary 3
... Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY ) announced today that ... clinical trial to investigate the use of REOLYSIN(R) for patients with ... James Markert , Division Director of Neurosurgery, and Professor, Neurosurgery and ... , , ...
... Moffitt Cancer Center announces steadily growing interest in the ERCC1 ... Lung Cancer patients.  Each year, more than 200,000 Americans are diagnosed ... , ... response to cisplatin-based chemotherapy.   The correlation between ERCC1 levels and ...
... ... databases with the launching of PrescriberPRO@Home. This Database will allow marketers to send targeted ... or email address. , ... (Vocus) April 23, 2010 -- Healthcare Data Solutions (HDS) has recently ...
Cached Biology Technology:Oncolytics Biotech(R) Inc. Completes Patient Enrollment in Phase I Portion of U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial 2Oncolytics Biotech(R) Inc. Completes Patient Enrollment in Phase I Portion of U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial 3Moffitt Cancer Center Announces Growing Interest in Recently Launched Prognostic Test for Non-Small Cell Lung Cancer 2Moffitt Cancer Center Announces Growing Interest in Recently Launched Prognostic Test for Non-Small Cell Lung Cancer 3Moffitt Cancer Center Announces Growing Interest in Recently Launched Prognostic Test for Non-Small Cell Lung Cancer 4Healthcare Data Solutions Announces Latest Database, PrescriberPRO@Home. 2Healthcare Data Solutions Announces Latest Database, PrescriberPRO@Home. 3
Anti Autotaxin /ENPP2 , - (Rabbit)...
... An N-nitroso-containing diabetogenic compound that acts ... pancreatic islets. An antibiotic effective against ... DNA strand breaks in pancreatic islet ... in H 2 O. RTECS LZ5775000, ...
Mouse monoclonal antibody to CDC2L5 - cell division cycle 2-like 5 (cholinesterase-related cell division controller)...
... The pACHLT-A-BFP Baculovirus Transfer Vector is a derivative ... the gene for blue fluorescent protein (BFP), followed ... site (MCS).,Foreign genes are expressed as BFP-6xHis fusion ... restriction enzyme,sites (EcoR I, Stu I, Sac I, ...
Biology Products: